# TDAC (Translational Development Acquisition Corp.) - SEC EDGAR Financial Statements

> Translational Development Acquisition Corp. reported $159.4M in total assets and a net loss of $5.42M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TDAC
- Markdown: https://convexityos.com/fundamentals/TDAC.md
- SEC CIK: 0001926599
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001926599&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$1.65M | Operating profit |
| Net Income | FY 2025 | -$5.42M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $86K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Income** | -$945K | -$196K | -$486K |
| Income Tax Expense | -- | $0 | -- |
| **Net Income** | $6.36M | -$71K | -$486K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Income** | -$548K | -$661K | -$281K | -$162K | -$214K | -$221K | -$347K | -$133K |
| Income Tax Expense | $0 | $0 | $0 | -- | $0 | $0 | $0 | -- |
| **Net Income** | -$9.29M | $947K | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -$8.0K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $30K | $438K | $2.0K |
| **Cash & Short-Term Investments** | $30K | $438K | $2.0K |
| **Total Current Assets** | $39K | $650K | $2.0K |
| **Total Non-Current Assets** | $181.7M | $174.4M | $0 |
| **Total Assets** | $181.7M | $175.0M | $2.0K |
| Accounts Payable | -- | $16K | $1.3K |
| Other Current Liabilities | $107K | $2.0K | -- |
| **Total Current Liabilities** | $544K | $210K | $510K |
| **Total Non-Current Liabilities** | $6.04M | $6.04M | $0 |
| **Total Liabilities** | $6.58M | $6.25M | $510K |
| Retained Earnings | -$6.54M | -$5.60M | -$533K |
| **Total Stockholders' Equity** | -$6.54M | -$5.60M | -$508K |
| Total Equity | -$6.54M | -$5.60M | -$508K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $86K | $86K | $25K | $30K | $47K | $35K | $207K | $438K |
| **Cash & Short-Term Investments** | $86K | $86K | $25K | $30K | $47K | $35K | $207K | $438K |
| **Total Current Assets** | $90K | $105K | $75K | $39K | $81K | $156K | $415K | $650K |
| **Total Non-Current Assets** | $159.3M | $157.3M | $183.3M | $181.7M | $179.9M | $178.0M | $176.2M | $174.4M |
| **Total Assets** | $159.4M | $157.4M | $183.3M | $181.7M | $180.0M | $178.2M | $176.6M | $175.0M |
| Accounts Payable | -- | -- | -- | -- | -- | -- | -- | $16K |
| Other Current Liabilities | $190K | $167K | $137K | $107K | $77K | $47K | $22K | $2.0K |
| **Total Current Liabilities** | $2.88M | $1.75M | $861K | $544K | $423K | $285K | $323K | $210K |
| **Total Non-Current Liabilities** | $16.24M | $6.04M | $6.04M | $6.04M | $6.04M | $6.04M | $6.04M | $6.04M |
| **Total Liabilities** | $19.12M | $7.79M | $6.90M | $6.58M | $6.46M | $6.32M | $6.36M | $6.25M |
| Retained Earnings | -$19.03M | -$7.68M | -$6.82M | -$6.54M | -$6.38M | -$6.17M | -$5.95M | -$5.60M |
| **Total Stockholders' Equity** | -$19.03M | -$7.68M | -$6.82M | -$6.54M | -$6.38M | -$6.17M | -$5.94M | -$5.60M |
| Total Equity | -$19.03M | -$7.68M | -$6.82M | -$6.54M | -$6.38M | -$6.17M | -$5.94M | -$5.60M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | $6.36M | -$71K | -$486K |
| **Operating Cash Flow** | -$608K | -$851K | -$204 |
| Purchases of Investments | -- | -$174.2M | -- |
| **Investing Cash Flow** | -- | -$174.2M | -- |
| **Financing Cash Flow** | $200K | $175.5M | -- |
| **Net Change in Cash** | -$408K | $436K | -$204 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$9.29M | $947K | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -$8.0K |
| **Operating Cash Flow** | -$375K | -$339K | -$305K | -$117K | -$88K | -$171K | -$232K | -- |
| **Financing Cash Flow** | $975K | -$27.22M | $300K | -- | -- | -- | -- | -- |
| **Net Change in Cash** | -$25 | $61K | -$5.2K | -$17K | $12K | -$171K | -$232K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Assets (ROA) | 3.5% | 0.0% | -24025.2% |
| Current Ratio | 0.07x | 3.09x | 0.00x |
| Quick Ratio | 0.05x | 2.08x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -3.4% | 3.5% | 3.4% | 3.5% | 2.6% | 1.7% | 0.8% | 0.0% |
| Current Ratio | 0.03x | 0.06x | 0.09x | 0.07x | 0.19x | 0.55x | 1.29x | 3.09x |
| Quick Ratio | 0.03x | 0.05x | 0.03x | 0.05x | 0.11x | 0.12x | 0.64x | 2.08x |
| **Net Income Growth (YoY)** | -659.8% | -41.7% | -10.1% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
